Superbug Sickens Dozens in Illinois

A single hospital was at the epicenter of an outbreak of antibiotic-resistant bacteria.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The suburban Chicago hospital where dozens of patients were infected with CREWIKIMEDIA, ZOL87Nearly 50 people in the Chicago area have turned up with infections involving a relatively new and virulent bacterium, and a suburban hospital appears to be a major contributor to the outbreak. The US Centers for Disease Control and Prevention (CDC) reported last week (January 3) that 44 people in northeastern Illinois were infected with carbapenem-resistant Enterobacteriaceae (CRE), a bacterium that is highly resistant to treatment, and one the agency last year deemed an urgent threat to public health. Of the 44 affected, 38 were patients who underwent endoscopic procedures involving the pancreas or bile ducts at Advocate Lutheran General Hospital in Park Ridge, IL, between January and September 2013.

“It’s the largest outbreak that we’ve seen in the U.S. of this bacteri[um] ever,” Alex Kallen, a CDC infectious disease doctor involved with the investigation of the outbreak, told CBS Chicago.

In total, 243 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) at Advocate Lutheran were exposed to the bacterium, but most people were only “colonized,” not infected with the pathogen. According to the hospital, 28 patients tested positive for the microbe, but did not show signs of an infection, and 10 others did exhibit symptoms of infection. “The design of the ERCP endoscopes might pose a particular challenge for cleaning and disinfection,” according to the CDC report.

In the U.S., CRE was first reported in 2009, and through 2012, only 27 infected patients have been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo